HEADER HYDRALASE/INHIBITOR 21-FEB-19 6JIJ TITLE THE CRYSTAL STRUCTURE OF MAIN PROTEASE FROM MOUSE HEPATITIS VIRUS A59 TITLE 2 IN COMPLEX WITH AN INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: REPLICATIVE POLYPROTEIN 1AB; COMPND 3 CHAIN: B, C, A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: 02J-ALA-VAL-LEU-PJE-010; COMPND 7 CHAIN: D, E, F; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MURINE CORONAVIRUS (STRAIN A59); SOURCE 3 ORGANISM_COMMON: MHV-A59; SOURCE 4 ORGANISM_TAXID: 11142; SOURCE 5 STRAIN: A59; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 11 ORGANISM_TAXID: 32630 KEYWDS MAIN PROTEASE, MOUSE HEPATITIS VIRUS A59, HYDRALASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR W.CUI,S.S.CUI REVDAT 4 23-OCT-24 6JIJ 1 REMARK REVDAT 3 15-NOV-23 6JIJ 1 LINK ATOM REVDAT 2 19-FEB-20 6JIJ 1 REMARK SITE REVDAT 1 24-APR-19 6JIJ 0 JRNL AUTH W.CUI,S.CUI,C.CHEN,X.CHEN,Z.WANG,H.YANG,L.ZHANG JRNL TITL THE CRYSTAL STRUCTURE OF MAIN PROTEASE FROM MOUSE HEPATITIS JRNL TITL 2 VIRUS A59 IN COMPLEX WITH AN INHIBITOR. JRNL REF BIOCHEM. BIOPHYS. RES. V. 511 794 2019 JRNL REF 2 COMMUN. JRNL REFN ESSN 1090-2104 JRNL PMID 30833083 JRNL DOI 10.1016/J.BBRC.2019.02.105 REMARK 2 REMARK 2 RESOLUTION. 2.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.14_3260: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.96 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 29710 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.229 REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.270 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 1502 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 36.9647 - 5.8753 0.99 2645 158 0.1782 0.2045 REMARK 3 2 5.8753 - 4.6664 1.00 2589 145 0.1954 0.2445 REMARK 3 3 4.6664 - 4.0774 1.00 2568 131 0.1927 0.2636 REMARK 3 4 4.0774 - 3.7049 1.00 2585 150 0.2303 0.2692 REMARK 3 5 3.7049 - 3.4396 1.00 2586 116 0.2543 0.3002 REMARK 3 6 3.4396 - 3.2369 1.00 2555 145 0.2797 0.3222 REMARK 3 7 3.2369 - 3.0749 1.00 2569 131 0.2756 0.2901 REMARK 3 8 3.0749 - 2.9411 1.00 2576 137 0.2895 0.3062 REMARK 3 9 2.9411 - 2.8279 1.00 2536 140 0.2764 0.3615 REMARK 3 10 2.8279 - 2.7304 0.99 2564 126 0.2936 0.3456 REMARK 3 11 2.7304 - 2.6450 0.95 2435 123 0.3087 0.3862 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.380 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.250 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 7156 REMARK 3 ANGLE : 0.772 9736 REMARK 3 CHIRALITY : 0.050 1109 REMARK 3 PLANARITY : 0.004 1243 REMARK 3 DIHEDRAL : 13.557 4126 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6JIJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 06-MAR-19. REMARK 100 THE DEPOSITION ID IS D_1300011177. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-SEP-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97854 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29741 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.70 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M SODIUM ACETATE TRIHYDRATE (PH 4.4 REMARK 280 -4.6), 8%-10%(W/V) POLYETHYLENE GLYCOL 4,000, MICROBATCH, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 83.89350 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.01700 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 83.89350 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 32.01700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A, D, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, E REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 98.50594 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 95.46227 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)- REMARK 400 4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL) REMARK 400 -L-LEUCINAMIDE IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R, REMARK 400 2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL] REMARK 400 METHYL}BUT-2-ENYL)-L-LEUCINAMIDE REMARK 400 CHAIN: D, E, F REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL B 298 REMARK 465 LYS B 299 REMARK 465 LEU B 300 REMARK 465 GLN B 301 REMARK 465 LYS C 299 REMARK 465 LEU C 300 REMARK 465 GLN C 301 REMARK 465 VAL A 298 REMARK 465 LYS A 299 REMARK 465 LEU A 300 REMARK 465 GLN A 301 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 SG CYS C 143 C20 PJE E 5 1.76 REMARK 500 SG CYS B 143 C20 PJE D 5 1.77 REMARK 500 SG CYS A 143 C20 PJE F 5 1.77 REMARK 500 OG SER B 1 O PHE A 138 2.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 CD1 LEU B 244 C3 010 F 6 2555 1.50 REMARK 500 CD1 LEU B 244 C2 010 F 6 2555 1.76 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 VAL D 3 C LEU D 4 N 0.144 REMARK 500 VAL E 3 C LEU E 4 N 0.142 REMARK 500 VAL F 3 C LEU F 4 N 0.148 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 244 CA - CB - CG ANGL. DEV. = 17.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP B 33 -121.17 54.98 REMARK 500 CYS B 44 -79.59 -101.13 REMARK 500 SER B 45 -31.42 77.82 REMARK 500 ASP B 46 34.86 -93.83 REMARK 500 MET B 47 -177.07 59.48 REMARK 500 THR B 48 -124.79 42.47 REMARK 500 GLN B 162 -36.41 -142.21 REMARK 500 GLN B 187 42.94 -83.27 REMARK 500 ARG B 213 -63.32 66.04 REMARK 500 ASN B 215 22.07 -142.77 REMARK 500 ALA B 296 -71.08 -129.47 REMARK 500 ASP C 33 -118.57 58.43 REMARK 500 MET C 47 157.04 74.57 REMARK 500 ASP C 49 77.40 -151.86 REMARK 500 ASP C 51 58.98 -101.02 REMARK 500 GLN C 162 -29.65 -142.29 REMARK 500 PRO C 182 46.50 -91.04 REMARK 500 GLN C 187 46.54 -85.62 REMARK 500 ASN C 212 31.14 -98.89 REMARK 500 ASP A 33 -120.54 57.66 REMARK 500 CYS A 44 -81.13 -91.14 REMARK 500 SER A 45 -3.94 63.94 REMARK 500 MET A 47 178.18 58.87 REMARK 500 THR A 48 -114.34 44.80 REMARK 500 ASP A 51 69.75 -114.78 REMARK 500 THR A 151 71.61 -105.81 REMARK 500 GLN A 162 -30.19 -144.20 REMARK 500 SER A 269 31.40 -93.55 REMARK 500 ALA A 296 -57.38 -128.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 505 DISTANCE = 5.94 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: CHAIN REMARK 800 SITE_DESCRIPTION: binding site for "N-[(5-METHYLISOXAZOL-3 REMARK 800 -YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{ REMARK 800 [(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: NULL REMARK 800 SITE_DESCRIPTION: NULL REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: NULL REMARK 800 SITE_DESCRIPTION: NULL DBREF 6JIJ B 1 301 UNP Q66WN6 Q66WN6_CVMA5 3334 3636 DBREF 6JIJ C 1 301 UNP Q66WN6 Q66WN6_CVMA5 3334 3636 DBREF 6JIJ A 1 301 UNP Q66WN6 Q66WN6_CVMA5 3334 3636 DBREF 6JIJ D 1 6 PDB 6JIJ 6JIJ 1 6 DBREF 6JIJ E 1 6 PDB 6JIJ 6JIJ 1 6 DBREF 6JIJ F 1 6 PDB 6JIJ 6JIJ 1 6 SEQADV 6JIJ B UNP Q66WN6 SER 3379 DELETION SEQADV 6JIJ B UNP Q66WN6 ALA 3380 DELETION SEQADV 6JIJ PHE B 282 UNP Q66WN6 LEU 3617 CONFLICT SEQADV 6JIJ C UNP Q66WN6 SER 3379 DELETION SEQADV 6JIJ C UNP Q66WN6 ALA 3380 DELETION SEQADV 6JIJ PHE C 282 UNP Q66WN6 LEU 3617 CONFLICT SEQADV 6JIJ A UNP Q66WN6 SER 3379 DELETION SEQADV 6JIJ A UNP Q66WN6 ALA 3380 DELETION SEQADV 6JIJ PHE A 282 UNP Q66WN6 LEU 3617 CONFLICT SEQRES 1 B 301 SER GLY ILE VAL LYS MET VAL SER PRO THR SER LYS VAL SEQRES 2 B 301 GLU PRO CYS ILE VAL SER VAL THR TYR GLY ASN MET THR SEQRES 3 B 301 LEU ASN GLY LEU TRP LEU ASP ASP LYS VAL TYR CYS PRO SEQRES 4 B 301 ARG HIS VAL ILE CYS SER ASP MET THR ASP PRO ASP TYR SEQRES 5 B 301 PRO ASN LEU LEU CYS ARG VAL THR SER SER ASP PHE CYS SEQRES 6 B 301 VAL MET SER GLY ARG MET SER LEU THR VAL MET SER TYR SEQRES 7 B 301 GLN MET GLN GLY CYS GLN LEU VAL LEU THR VAL THR LEU SEQRES 8 B 301 GLN ASN PRO ASN THR PRO LYS TYR SER PHE GLY VAL VAL SEQRES 9 B 301 LYS PRO GLY GLU THR PHE THR VAL LEU ALA ALA TYR ASN SEQRES 10 B 301 GLY ARG PRO GLN GLY ALA PHE HIS VAL THR LEU ARG SER SEQRES 11 B 301 SER HIS THR ILE LYS GLY SER PHE LEU CYS GLY SER CYS SEQRES 12 B 301 GLY SER VAL GLY TYR VAL LEU THR GLY ASP SER VAL ARG SEQRES 13 B 301 PHE VAL TYR MET HIS GLN LEU GLU LEU SER THR GLY CYS SEQRES 14 B 301 HIS THR GLY THR ASP PHE SER GLY ASN PHE TYR GLY PRO SEQRES 15 B 301 TYR ARG ASP ALA GLN VAL VAL GLN LEU PRO VAL GLN ASP SEQRES 16 B 301 TYR THR GLN THR VAL ASN VAL VAL ALA TRP LEU TYR ALA SEQRES 17 B 301 ALA ILE PHE ASN ARG CYS ASN TRP PHE VAL GLN SER ASP SEQRES 18 B 301 SER CYS SER LEU GLU GLU PHE ASN VAL TRP ALA MET THR SEQRES 19 B 301 ASN GLY PHE SER SER ILE LYS ALA ASP LEU VAL LEU ASP SEQRES 20 B 301 ALA LEU ALA SER MET THR GLY VAL THR VAL GLU GLN VAL SEQRES 21 B 301 LEU ALA ALA ILE LYS ARG LEU HIS SER GLY PHE GLN GLY SEQRES 22 B 301 LYS GLN ILE LEU GLY SER CYS VAL PHE GLU ASP GLU LEU SEQRES 23 B 301 THR PRO SER ASP VAL TYR GLN GLN LEU ALA GLY VAL LYS SEQRES 24 B 301 LEU GLN SEQRES 1 C 301 SER GLY ILE VAL LYS MET VAL SER PRO THR SER LYS VAL SEQRES 2 C 301 GLU PRO CYS ILE VAL SER VAL THR TYR GLY ASN MET THR SEQRES 3 C 301 LEU ASN GLY LEU TRP LEU ASP ASP LYS VAL TYR CYS PRO SEQRES 4 C 301 ARG HIS VAL ILE CYS SER ASP MET THR ASP PRO ASP TYR SEQRES 5 C 301 PRO ASN LEU LEU CYS ARG VAL THR SER SER ASP PHE CYS SEQRES 6 C 301 VAL MET SER GLY ARG MET SER LEU THR VAL MET SER TYR SEQRES 7 C 301 GLN MET GLN GLY CYS GLN LEU VAL LEU THR VAL THR LEU SEQRES 8 C 301 GLN ASN PRO ASN THR PRO LYS TYR SER PHE GLY VAL VAL SEQRES 9 C 301 LYS PRO GLY GLU THR PHE THR VAL LEU ALA ALA TYR ASN SEQRES 10 C 301 GLY ARG PRO GLN GLY ALA PHE HIS VAL THR LEU ARG SER SEQRES 11 C 301 SER HIS THR ILE LYS GLY SER PHE LEU CYS GLY SER CYS SEQRES 12 C 301 GLY SER VAL GLY TYR VAL LEU THR GLY ASP SER VAL ARG SEQRES 13 C 301 PHE VAL TYR MET HIS GLN LEU GLU LEU SER THR GLY CYS SEQRES 14 C 301 HIS THR GLY THR ASP PHE SER GLY ASN PHE TYR GLY PRO SEQRES 15 C 301 TYR ARG ASP ALA GLN VAL VAL GLN LEU PRO VAL GLN ASP SEQRES 16 C 301 TYR THR GLN THR VAL ASN VAL VAL ALA TRP LEU TYR ALA SEQRES 17 C 301 ALA ILE PHE ASN ARG CYS ASN TRP PHE VAL GLN SER ASP SEQRES 18 C 301 SER CYS SER LEU GLU GLU PHE ASN VAL TRP ALA MET THR SEQRES 19 C 301 ASN GLY PHE SER SER ILE LYS ALA ASP LEU VAL LEU ASP SEQRES 20 C 301 ALA LEU ALA SER MET THR GLY VAL THR VAL GLU GLN VAL SEQRES 21 C 301 LEU ALA ALA ILE LYS ARG LEU HIS SER GLY PHE GLN GLY SEQRES 22 C 301 LYS GLN ILE LEU GLY SER CYS VAL PHE GLU ASP GLU LEU SEQRES 23 C 301 THR PRO SER ASP VAL TYR GLN GLN LEU ALA GLY VAL LYS SEQRES 24 C 301 LEU GLN SEQRES 1 A 301 SER GLY ILE VAL LYS MET VAL SER PRO THR SER LYS VAL SEQRES 2 A 301 GLU PRO CYS ILE VAL SER VAL THR TYR GLY ASN MET THR SEQRES 3 A 301 LEU ASN GLY LEU TRP LEU ASP ASP LYS VAL TYR CYS PRO SEQRES 4 A 301 ARG HIS VAL ILE CYS SER ASP MET THR ASP PRO ASP TYR SEQRES 5 A 301 PRO ASN LEU LEU CYS ARG VAL THR SER SER ASP PHE CYS SEQRES 6 A 301 VAL MET SER GLY ARG MET SER LEU THR VAL MET SER TYR SEQRES 7 A 301 GLN MET GLN GLY CYS GLN LEU VAL LEU THR VAL THR LEU SEQRES 8 A 301 GLN ASN PRO ASN THR PRO LYS TYR SER PHE GLY VAL VAL SEQRES 9 A 301 LYS PRO GLY GLU THR PHE THR VAL LEU ALA ALA TYR ASN SEQRES 10 A 301 GLY ARG PRO GLN GLY ALA PHE HIS VAL THR LEU ARG SER SEQRES 11 A 301 SER HIS THR ILE LYS GLY SER PHE LEU CYS GLY SER CYS SEQRES 12 A 301 GLY SER VAL GLY TYR VAL LEU THR GLY ASP SER VAL ARG SEQRES 13 A 301 PHE VAL TYR MET HIS GLN LEU GLU LEU SER THR GLY CYS SEQRES 14 A 301 HIS THR GLY THR ASP PHE SER GLY ASN PHE TYR GLY PRO SEQRES 15 A 301 TYR ARG ASP ALA GLN VAL VAL GLN LEU PRO VAL GLN ASP SEQRES 16 A 301 TYR THR GLN THR VAL ASN VAL VAL ALA TRP LEU TYR ALA SEQRES 17 A 301 ALA ILE PHE ASN ARG CYS ASN TRP PHE VAL GLN SER ASP SEQRES 18 A 301 SER CYS SER LEU GLU GLU PHE ASN VAL TRP ALA MET THR SEQRES 19 A 301 ASN GLY PHE SER SER ILE LYS ALA ASP LEU VAL LEU ASP SEQRES 20 A 301 ALA LEU ALA SER MET THR GLY VAL THR VAL GLU GLN VAL SEQRES 21 A 301 LEU ALA ALA ILE LYS ARG LEU HIS SER GLY PHE GLN GLY SEQRES 22 A 301 LYS GLN ILE LEU GLY SER CYS VAL PHE GLU ASP GLU LEU SEQRES 23 A 301 THR PRO SER ASP VAL TYR GLN GLN LEU ALA GLY VAL LYS SEQRES 24 A 301 LEU GLN SEQRES 1 D 6 02J ALA VAL LEU PJE 010 SEQRES 1 E 6 02J ALA VAL LEU PJE 010 SEQRES 1 F 6 02J ALA VAL LEU PJE 010 HET 02J D 1 8 HET PJE D 5 13 HET 010 D 6 8 HET 02J E 1 8 HET PJE E 5 13 HET 010 E 6 8 HET 02J F 1 8 HET PJE F 5 13 HET 010 F 6 8 HETNAM 02J 5-METHYL-1,2-OXAZOLE-3-CARBOXYLIC ACID HETNAM PJE (E,4S)-4-AZANYL-5-[(3S)-2-OXIDANYLIDENEPYRROLIDIN-3- HETNAM 2 PJE YL]PENT-2-ENOIC ACID HETNAM 010 PHENYLMETHANOL FORMUL 4 02J 3(C5 H5 N O3) FORMUL 4 PJE 3(C9 H14 N2 O3) FORMUL 4 010 3(C7 H8 O) FORMUL 7 HOH *11(H2 O) HELIX 1 AA1 VAL B 13 PRO B 15 5 3 HELIX 2 AA2 HIS B 41 CYS B 44 5 4 HELIX 3 AA3 ASP B 51 VAL B 59 1 9 HELIX 4 AA4 THR B 60 PHE B 64 5 5 HELIX 5 AA5 GLN B 198 ASN B 212 1 15 HELIX 6 AA6 SER B 224 MET B 233 1 10 HELIX 7 AA7 ASP B 243 GLY B 254 1 12 HELIX 8 AA8 THR B 256 HIS B 268 1 13 HELIX 9 AA9 THR B 287 ALA B 296 1 10 HELIX 10 AB1 VAL C 13 PRO C 15 5 3 HELIX 11 AB2 HIS C 41 CYS C 44 5 4 HELIX 12 AB3 ASP C 51 LEU C 56 1 6 HELIX 13 AB4 CYS C 57 VAL C 59 5 3 HELIX 14 AB5 THR C 60 SER C 62 5 3 HELIX 15 AB6 GLN C 198 ASN C 212 1 15 HELIX 16 AB7 SER C 224 MET C 233 1 10 HELIX 17 AB8 ASP C 243 GLY C 254 1 12 HELIX 18 AB9 THR C 256 LEU C 267 1 12 HELIX 19 AC1 THR C 287 ALA C 296 1 10 HELIX 20 AC2 VAL A 13 PRO A 15 5 3 HELIX 21 AC3 HIS A 41 CYS A 44 5 4 HELIX 22 AC4 ASP A 51 VAL A 59 1 9 HELIX 23 AC5 THR A 60 SER A 62 5 3 HELIX 24 AC6 GLN A 198 ASN A 212 1 15 HELIX 25 AC7 SER A 224 MET A 233 1 10 HELIX 26 AC8 ASP A 243 GLY A 254 1 12 HELIX 27 AC9 THR A 256 HIS A 268 1 13 HELIX 28 AD1 THR A 287 GLN A 294 1 8 SHEET 1 AA1 7 MET B 71 LEU B 73 0 SHEET 2 AA1 7 CYS B 65 SER B 68 -1 N VAL B 66 O LEU B 73 SHEET 3 AA1 7 ILE B 17 TYR B 22 -1 N SER B 19 O MET B 67 SHEET 4 AA1 7 MET B 25 LEU B 32 -1 O GLY B 29 N VAL B 18 SHEET 5 AA1 7 LYS B 35 PRO B 39 -1 O LYS B 35 N LEU B 32 SHEET 6 AA1 7 GLN B 84 VAL B 89 -1 O LEU B 85 N CYS B 38 SHEET 7 AA1 7 VAL B 75 GLN B 81 -1 N MET B 76 O THR B 88 SHEET 1 AA2 5 TYR B 99 PHE B 101 0 SHEET 2 AA2 5 SER B 154 SER B 166 1 O VAL B 155 N SER B 100 SHEET 3 AA2 5 VAL B 146 THR B 151 -1 N THR B 151 O SER B 154 SHEET 4 AA2 5 THR B 109 TYR B 116 -1 N LEU B 113 O VAL B 146 SHEET 5 AA2 5 ARG B 119 THR B 127 -1 O GLN B 121 N ALA B 114 SHEET 1 AA3 3 TYR B 99 PHE B 101 0 SHEET 2 AA3 3 SER B 154 SER B 166 1 O VAL B 155 N SER B 100 SHEET 3 AA3 3 CYS B 169 THR B 173 -1 O THR B 171 N LEU B 163 SHEET 1 AA4 7 MET C 71 LEU C 73 0 SHEET 2 AA4 7 PHE C 64 SER C 68 -1 N SER C 68 O MET C 71 SHEET 3 AA4 7 ILE C 17 TYR C 22 -1 N THR C 21 O CYS C 65 SHEET 4 AA4 7 MET C 25 LEU C 32 -1 O GLY C 29 N VAL C 18 SHEET 5 AA4 7 LYS C 35 PRO C 39 -1 O LYS C 35 N LEU C 32 SHEET 6 AA4 7 GLN C 84 VAL C 89 -1 O LEU C 85 N CYS C 38 SHEET 7 AA4 7 VAL C 75 SER C 77 -1 N SER C 77 O THR C 88 SHEET 1 AA5 7 MET C 71 LEU C 73 0 SHEET 2 AA5 7 PHE C 64 SER C 68 -1 N SER C 68 O MET C 71 SHEET 3 AA5 7 ILE C 17 TYR C 22 -1 N THR C 21 O CYS C 65 SHEET 4 AA5 7 MET C 25 LEU C 32 -1 O GLY C 29 N VAL C 18 SHEET 5 AA5 7 LYS C 35 PRO C 39 -1 O LYS C 35 N LEU C 32 SHEET 6 AA5 7 GLN C 84 VAL C 89 -1 O LEU C 85 N CYS C 38 SHEET 7 AA5 7 MET C 80 GLN C 81 -1 N GLN C 81 O GLN C 84 SHEET 1 AA6 5 TYR C 99 PHE C 101 0 SHEET 2 AA6 5 VAL C 155 SER C 166 1 O VAL C 155 N SER C 100 SHEET 3 AA6 5 VAL C 146 LEU C 150 -1 N VAL C 149 O ARG C 156 SHEET 4 AA6 5 THR C 109 TYR C 116 -1 N THR C 111 O TYR C 148 SHEET 5 AA6 5 ARG C 119 THR C 127 -1 O GLN C 121 N ALA C 114 SHEET 1 AA7 3 TYR C 99 PHE C 101 0 SHEET 2 AA7 3 VAL C 155 SER C 166 1 O VAL C 155 N SER C 100 SHEET 3 AA7 3 CYS C 169 THR C 173 -1 O THR C 173 N MET C 160 SHEET 1 AA8 7 MET A 71 LEU A 73 0 SHEET 2 AA8 7 PHE A 64 SER A 68 -1 N VAL A 66 O LEU A 73 SHEET 3 AA8 7 ILE A 17 TYR A 22 -1 N THR A 21 O CYS A 65 SHEET 4 AA8 7 MET A 25 LEU A 32 -1 O GLY A 29 N VAL A 18 SHEET 5 AA8 7 LYS A 35 PRO A 39 -1 O LYS A 35 N LEU A 32 SHEET 6 AA8 7 GLN A 84 THR A 88 -1 O LEU A 85 N CYS A 38 SHEET 7 AA8 7 MET A 80 GLN A 81 -1 N GLN A 81 O GLN A 84 SHEET 1 AA9 5 TYR A 99 PHE A 101 0 SHEET 2 AA9 5 SER A 154 SER A 166 1 O VAL A 155 N SER A 100 SHEET 3 AA9 5 VAL A 146 THR A 151 -1 N GLY A 147 O VAL A 158 SHEET 4 AA9 5 THR A 109 TYR A 116 -1 N THR A 111 O TYR A 148 SHEET 5 AA9 5 ARG A 119 THR A 127 -1 O GLN A 121 N ALA A 114 SHEET 1 AB1 3 TYR A 99 PHE A 101 0 SHEET 2 AB1 3 SER A 154 SER A 166 1 O VAL A 155 N SER A 100 SHEET 3 AB1 3 CYS A 169 THR A 173 -1 O THR A 173 N MET A 160 LINK C 02J D 1 N ALA D 2 1555 1555 1.45 LINK C LEU D 4 N PJE D 5 1555 1555 1.46 LINK C PJE D 5 O 010 D 6 1555 1555 1.43 LINK C 02J E 1 N ALA E 2 1555 1555 1.45 LINK C LEU E 4 N PJE E 5 1555 1555 1.46 LINK C PJE E 5 O 010 E 6 1555 1555 1.44 LINK C 02J F 1 N ALA F 2 1555 1555 1.45 LINK C LEU F 4 N PJE F 5 1555 1555 1.46 LINK C PJE F 5 O 010 F 6 1555 1555 1.42 SITE 1 AC1 16 MET B 25 HIS B 41 PHE B 138 LEU B 139 SITE 2 AC1 16 GLY B 141 SER B 142 CYS B 143 HIS B 161 SITE 3 AC1 16 GLN B 162 LEU B 163 GLU B 164 HIS B 170 SITE 4 AC1 16 GLN B 187 VAL B 188 VAL B 189 010 E 6 SITE 1 AC2 20 ASP B 46 MET B 47 MET C 25 HIS C 41 SITE 2 AC2 20 TYR C 52 PHE C 138 LEU C 139 CYS C 140 SITE 3 AC2 20 GLY C 141 CYS C 143 HIS C 161 GLN C 162 SITE 4 AC2 20 LEU C 163 GLU C 164 HIS C 170 ASP C 185 SITE 5 AC2 20 GLN C 187 VAL C 188 VAL C 189 02J D 1 SITE 1 AC3 14 MET A 25 HIS A 41 PHE A 138 GLY A 141 SITE 2 AC3 14 CYS A 143 HIS A 161 GLN A 162 LEU A 163 SITE 3 AC3 14 GLU A 164 HIS A 170 GLN A 187 VAL A 188 SITE 4 AC3 14 VAL A 189 LEU B 244 CRYST1 167.787 64.034 117.953 90.00 125.97 90.00 C 1 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005960 0.000000 0.004326 0.00000 SCALE2 0.000000 0.015617 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010476 0.00000